Predict your next investment

Private Equity
ampersandcapital.com

See what CB Insights has to offer

Investments

137

Portfolio Exits

58

Funds

18

Partners & Customers

1

Service Providers

2

About Ampersand Capital Partners

Ampersand Capital Partners is a middle market private equity firm focused on investments in the Healthcare and Industrial sectors. It prefers to be the first, and usually sole, institutional investor.

Ampersand Capital Partners Headquarters Location

55 William St Suite 240

Wellesley, Massachusetts, 02481,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Ampersand Capital Partners

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Ampersand Capital Partners in 2 Expert Collections, including Vitamin & Supplement Startups.

V

Vitamin & Supplement Startups

237 items

S

Synthetic Biology

382 items

Latest Ampersand Capital Partners News

Ampersand Capital Partners Invests in Sterling Medical Devices

Aug 5, 2022

Sterling's capabilities include the development of entire systems, including the incorporation of software, electronics, and mechanical components. Michael Barbella, Managing Editor08.05.22 Ampersand Capital Partners  is investing in Sterling Medical Devices , a provider of design, development and regulatory services to the medical device industry. Details of the investment were not immediately available. “My team and I are humbled to join the Ampersand family. The Ampersand team’s extensive experience and network in the medical device industry positions Sterling to continue its strong growth trajectory and build on the world-class services we provide to our customers” said Dan Sterling, president and CEO of Sterling. Having successfully completed more than 1,500 projects for hundreds of unique customers, Sterling has commercialization experience across the entire medical device development process. Capabilities include the development of entire systems, including the incorporation of software, electronics, and mechanical components. These services are provided by U.S.-based personnel in an ISO-13485 environment, and all supported by the company’s Regulatory Affairs and Quality Assurance capabilities. “We are thrilled to be partnering with Dan and the entire Sterling team. With over two decades of experience bringing the most complex medical devices to market, the Sterling team has built a strong, solutions-oriented reputation with the medical device industry’s leading innovators," said Trevor Wahlbrink, a partner at Ampersand. "We look forward to building upon the company’s strong momentum by continuing to add capabilities to its already robust offering.”   Located in Moonachie, N.J., Sterling Medical Devices provides custom electromechanical and software solutions for the medical device industry. For more than 21 years, the company’s experience in product development has helped healthcare companies bring their medical device software and hardware, electromechanical equipment, and mobile medical device apps to market. Sterling addresses the entire development process including systems, software, electronics, mechanical, quality, compliance, and regulatory affairs. Founded in 1988, Ampersand is a middle market private equity firm with more than $2 billion of assets under management dedicated to growth-oriented investments in the healthcare sector. With offices in Boston and Amsterdam, Ampersand leverages its blend of private equity and operating experience to build value and drive superior long-term performance alongside its portfolio company management teams. Ampersand has helped build numerous market-leading companies across each of the firm’s core healthcare sectors. Trending

Ampersand Capital Partners Investments

137 Investments

Ampersand Capital Partners has made 137 investments. Their latest investment was in Sterling Medical Devices as part of their Private Equity on June 6, 2022.

CBI Logo

Ampersand Capital Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

6/23/2022

Private Equity

Sterling Medical Devices

Yes

1

6/7/2022

Series C - II

AnaBios

$6.5M

Yes

2

5/25/2022

Series A

Vernal Biosciences

$21M

Yes

2

3/29/2022

Private Equity

Subscribe to see more

$99M

Subscribe to see more

10

3/1/2022

Private Equity

Subscribe to see more

Subscribe to see more

10

Date

6/23/2022

6/7/2022

5/25/2022

3/29/2022

3/1/2022

Round

Private Equity

Series C - II

Series A

Private Equity

Private Equity

Company

Sterling Medical Devices

AnaBios

Vernal Biosciences

Subscribe to see more

Subscribe to see more

Amount

$6.5M

$21M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

2

2

10

10

Ampersand Capital Partners Portfolio Exits

58 Portfolio Exits

Ampersand Capital Partners has 58 portfolio exits. Their latest portfolio exit was GenDx on August 17, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

8/17/2022

Acquired

$99M

2

2/18/2022

Acquired

$99M

3

2/18/2022

Acquired

$99M

2

1/12/2022

Merger

Subscribe to see more

$99M

Subscribe to see more

10

1/5/2022

Acq - Fin

Subscribe to see more

$99M

Subscribe to see more

10

Date

8/17/2022

2/18/2022

2/18/2022

1/12/2022

1/5/2022

Exit

Acquired

Acquired

Acquired

Merger

Acq - Fin

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

2

3

2

10

10

Ampersand Capital Partners Acquisitions

24 Acquisitions

Ampersand Capital Partners acquired 24 companies. Their latest acquisition was Protagen Protein Services on July 01, 2021.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

7/1/2021

$99M

Acq - Fin

1

9/21/2020

$99M

Acq - Fin

1

5/29/2019

$99M

Acq - Fin

4

9/4/2018

Subscribe to see more

$99M

Subscribe to see more

10

1/31/2017

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/1/2021

9/21/2020

5/29/2019

9/4/2018

1/31/2017

Investment Stage

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

Note

Acq - Fin

Acq - Fin

Acq - Fin

Subscribe to see more

Subscribe to see more

Sources

1

1

4

10

10

Ampersand Capital Partners Fund History

18 Fund Histories

Ampersand Capital Partners has 18 funds, including Ampersand Continuation Fund.

Closing Date

Fund

Fund Type

Status

Amount

Sources

11/19/2020

Ampersand Continuation Fund

$670M

2

3/31/2020

Ampersand 2020

Multi-Stage Venture Capital

Open

$690M

3

3/19/2018

Ampersand Capital Partners Fund I

Multi-Stage Venture Capital

Closed

$450M

1

5/29/2015

Ampersand 2014 LP

Subscribe to see more

Subscribe to see more

$99M

10

1/31/2011

Ampersand 2011 LP

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

11/19/2020

3/31/2020

3/19/2018

5/29/2015

1/31/2011

Fund

Ampersand Continuation Fund

Ampersand 2020

Ampersand Capital Partners Fund I

Ampersand 2014 LP

Ampersand 2011 LP

Fund Type

Multi-Stage Venture Capital

Multi-Stage Venture Capital

Subscribe to see more

Subscribe to see more

Status

Open

Closed

Subscribe to see more

Subscribe to see more

Amount

$670M

$690M

$450M

$99M

$99M

Sources

2

3

1

10

10

Ampersand Capital Partners Partners & Customers

1 Partners and customers

Ampersand Capital Partners has 1 strategic partners and customers. Ampersand Capital Partners recently partnered with GenDx on May 5, 2019.

Date

Type

Business Partner

Country

News Snippet

Sources

5/6/2019

Partner

Netherlands

Ampersand Capital backs GenDx

The partnership between Ampersand Capital Partners and GenDx aims to foster sustainable growth , both organically and through M&A activities in the molecular diagnostic products and services market .

5

Date

5/6/2019

Type

Partner

Business Partner

Country

Netherlands

News Snippet

Ampersand Capital backs GenDx

The partnership between Ampersand Capital Partners and GenDx aims to foster sustainable growth , both organically and through M&A activities in the molecular diagnostic products and services market .

Sources

5

Ampersand Capital Partners Service Providers

2 Service Providers

Ampersand Capital Partners has 2 service provider relationships

Service Provider

Associated Rounds

Provider Type

Service Type

Counsel

Subscribe to see more

Subscribe to see more

Service Provider

Subscribe to see more

Associated Rounds

Provider Type

Counsel

Subscribe to see more

Service Type

Partnership data by VentureSource

Ampersand Capital Partners Team

8 Team Members

Ampersand Capital Partners has 8 team members, including current Chief Financial Officer, Dana Niles.

Name

Work History

Title

Status

Richard A. Charpie

Founder

Current

Dana Niles

YankeeTek Ventures, and HLM Venture Partners

Chief Financial Officer

Current

Herbert H. Hooper

Managing Partner

Current

David Q. Anderson

General Partner

Current

Eric B. Lev

Water Street Healthcare Partners, Beckman Coulter, One Equity Partners, and Lehman Brothers

General Partner

Current

Name

Richard A. Charpie

Dana Niles

Herbert H. Hooper

David Q. Anderson

Eric B. Lev

Work History

YankeeTek Ventures, and HLM Venture Partners

Water Street Healthcare Partners, Beckman Coulter, One Equity Partners, and Lehman Brothers

Title

Founder

Chief Financial Officer

Managing Partner

General Partner

General Partner

Status

Current

Current

Current

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.